Nonviral gene editing via CRISPR/Cas9 delivery by membrane-disruptive and endosomolytic helical polypeptide.

about

Engineering Nanoparticles for Targeted Delivery of Nucleic Acid Therapeutics in Tumor CRISPR-delivery particles targeting nuclear receptor-interacting protein 1 () in adipose cells to enhance energy expenditure

P2860

Q58552610-54473DD2-F98C-4A8E-A1B9-6857235AD616 Q58760448-9D173108-D0AE-4A2E-B138-47E791E9AA32

P2860

Nonviral gene editing via CRISPR/Cas9 delivery by membrane-disruptive and endosomolytic helical polypeptide.

Item

http://www.wikidata.org/entity/Q52431811

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Nonviral gene editing via CRIS ...... somolytic helical polypeptide.

@en

Nonviral gene editing via CRIS ...... somolytic helical polypeptide.

@nl

type

Item

label

Nonviral gene editing via CRIS ...... somolytic helical polypeptide.

@en

Nonviral gene editing via CRIS ...... somolytic helical polypeptide.

@nl

prefLabel

Nonviral gene editing via CRIS ...... somolytic helical polypeptide.

@en

Nonviral gene editing via CRIS ...... somolytic helical polypeptide.

@nl

P1476

Nonviral gene editing via CRIS ...... somolytic helical polypeptide.

@en

P2093

Dantong Huang

http://www.w3.org/2001/XMLSchema#string

Hong-Xia Wang

http://www.w3.org/2001/XMLSchema#string

Jianjun Cheng

http://www.w3.org/2001/XMLSchema#string

Jing Gong

http://www.w3.org/2001/XMLSchema#string

Lichen Yin

http://www.w3.org/2001/XMLSchema#string

Mingqiang Li

http://www.w3.org/2001/XMLSchema#string

Syandan Chakraborty

http://www.w3.org/2001/XMLSchema#string

Xin Xu

http://www.w3.org/2001/XMLSchema#string

Ziyuan Song

http://www.w3.org/2001/XMLSchema#string

P2860

Therapeutic genome editing: prospects and challenges

Development and applications of CRISPR-Cas9 for genome engineering.

RNA-guided gene activation by CRISPR-Cas9-based transcription factors

Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo

Gene therapy progress and prospects: electroporation and other physical methods.

Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo

Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA.

Effect of genome size on AAV vector packaging.

Identification of mutations leading to the Lesch-Nyhan syndrome by automated direct DNA sequencing of in vitro amplified cDNA.

Self-assembled DNA nanoclews for the efficient delivery of CRISPR-Cas9 for genome editing.

P304

4903-4908

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1712963115

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-04-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29686087

http://www.w3.org/2001/XMLSchema#string

P921

CRISPR

P932

5948953

http://www.w3.org/2001/XMLSchema#string

Nonviral gene editing via CRISPR/Cas9 delivery by membrane-disruptive and endosomolytic helical polypeptide.

about

P2860

P2860

Nonviral gene editing via CRISPR/Cas9 delivery by membrane-disruptive and endosomolytic helical polypeptide.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932